ALNYLAM PHARMACEUTICALS, INC. Non-operating Income/Expense 2008-2025 | ALNY
Beta
What is ALNYLAM PHARMACEUTICALS, INC.'s current non-operating income/expense?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual non-operating income/expense for 2025 was $-178.4M, a 11.01% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. non-operating income/expense for the quarter ending December 31, 2025 was $-9.8M.
What was ALNYLAM PHARMACEUTICALS, INC.'s non-operating income/expense in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual non-operating income/expense for 2024 was $-200.5M, a 32.47% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s non-operating income/expense in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual non-operating income/expense for 2023 was $-151.3M, a 55.74% increase from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$57.3M
→
FY2025
$-178.4M
080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-178.4M | +11.0% | 10-K |
| FY2024 | $-200.5M | -32.5% | 10-K |
| FY2023 | $-151.3M | +55.7% | 10-K |
| FY2022 | $-341.9M | -138.3% | 10-K |
| FY2021 | $-143.5M | -350.3% | 10-K |
| FY2020 | $57.3M | +5.8% | 10-K |
| FY2019 | $54.2M | +0.3% | 10-K |
| FY2018 | $54.0M | +486.1% | 10-K |
| FY2017 | $9.2M | -36.4% | 10-K |
| FY2016 | $14.5M | +144.0% | 10-K |
| FY2015 | $5.9M | +35.6% | 10-K |
| FY2014 | $4.4M | +328.2% | 10-K |
| FY2013 | $1.0M | -92.1% | 10-K |
| FY2012 | $12.9M | +554.6% | 10-K |
| FY2011 | $-2.8M | -242.8% | 10-K |
| FY2010 | $2.0M | +79.7% | 10-K |
| FY2009 | $1.1M | -52.1% | 10-K |
| FY2008 | $2.3M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →